Currently holds positions in Biogaia AB and Infant Bacterial Therapeutics AB
Position | Company | Period |
---|---|---|
Chairman of the Board | Biogaia AB | April 25, 2018 - |
Chairman of the Board | Infant Bacterial Therapeutics AB | None - |
Group President | Biogaia AB | March 1, 2016 - April 25, 2018 |
Chief Executive Officer | Biogaia AB | Jan. 1, 1996 - March 1, 2016 |
Independent Director | Moberg Pharma AB (publ) | April 18, 2011 - May 13, 2014 |
Search
Notification date | Transaction date | B/S Transaction type |
Nb. shares Price Value |
Number of shares | Price | Total value | Details | |
---|---|---|---|---|---|---|---|---|
2021-05-06 | 2021-05-04 |
Infant Bacterial Therapeutics AB
(IBT-B)
|
B Purchase |
100,000
93.309,330,000 SEK |
100,000 | 93.30 | 9,330,000 SEK | |
2018-11-26 | 2018-11-23 |
Biogaia AB
(BIOG-B)
|
S Sale |
92,404
344.0031,786,976 SEK |
92,404 | 344.00 | 31,786,976 SEK | |
2018-11-22 | 2018-11-22 |
Biogaia AB
(BIOG-B)
|
S Sale |
52,896
344.0018,196,224 SEK |
52,896 | 344.00 | 18,196,224 SEK | |
2017-12-11 | 2017-12-07 |
Biogaia AB
(BIOG-B)
|
S Sale |
250,000
290.0072,500,000 SEK |
250,000 | 290.00 | 72,500,000 SEK |